Physician profile
Derek T Mitchell
NPI 1093744484
$3,543.76
in general payments reported to CMS, 2019-2025
14 companies · $543 in 2025
The $543 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $102 · 2021: $807 · 2022: $782 · 2023: $865 · 2024: $241 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $798.46 | 2021-2023 | Iovera |
| Avanos Medical | $716.75 | 2019-2025 | On-Q Pump and Accessories, On-Q* Pump and Accessories |
| Next Science LLC | $476.53 | 2022-2023 | Blastx, Xperience, Surgx |
| Edwards Lifesciences Corporation | $418.96 | 2022-2024 | Sapien 3 Ultra Resilia, Edwards Mc3 Tricuspid Annuloplasty Ring, Mitris Resilia Mitral Valve |
| Heron Therapeutics, INC. | $222.21 | 2021-2022 | |
| Octapharma USA, INC. | $195.18 | 2025 | Fibryga |
| Haemonetics Corporation | $145.06 | 2023-2025 | Teg6s Hemostasis System |
| Medtronic, INC. | $136.01 | 2022-2023 | Avalus |
| Acera Surgical, INC. | $120.00 | 2021 | |
| Medtronic USA, INC. | $110.53 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $109.35 | 2025 | |
| Atricure, INC. | $59.87 | 2019-2022 | |
| Kci USA, INC. | $20.46 | 2019 | |
| Merck Sharp & Dohme LLC | $14.39 | 2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.